Cellular Biomedicine Group partnered with GE Healthcare to accelerate its stem cell therapy manufacturing timeline.
Here are five insights:
1. CBMG’s facility in Shanghai, China, will utilize GE Healthcare’s FlexFactory platform, which is designed to speed up the manufacturing process for cell therapy clinical trials and commercial launches.
2. GE Healthcare developed FlexFactory as a semi-automated end-to-end platform. Getting a lab ready for industrial-scale manufacturing takes around nine months using the platform. The typical timeline can reach close to two years.
3. CBMG is the first company to install the FlexFactory for cell therapy, and it expects its facility to be up and running by the end of 2018.
4. In addition to development support, the FlexFactory will provide CBMG development and training services, cell processing equipment, semi-automation capabilities and digital connectivity solutions.
5. GE Healthcare works with the Centre for Commercialization of Regenerative Medicine to provide consumers development services, including cell technologies and protocol experts.